lung cancer | |||||||
新闻 | |||||||
Indapta Therapeutics Granted FDA Fast Track Designation for Natural Killer Cell Therapy for ... AstraZeneca VP, Head of US Lung Cancer Franchise Discusses the Recent FDA Approval of TAGRISSO.
| |||||||
Rare Disease Day 2024: How IARC is tackling rare cancers One example is the lungNENomics project, which aims to improve the diagnosis and clinical management of lung neuroendocrine tumours. Sharing. Close ...
| |||||||
查看更多结果 | 修改此快讯 |
您收到此电子邮件是因为您订阅了Google快讯。 |
以RSS Feed的形式接收此快讯 |
发送反馈 |
No comments:
Post a Comment